Immunocytometric Analysis of Oral Pemphigus vulgaris Patients after Treatment with Rituximab as Adjuvant

Immunocytometric Analysis of Oral Pemphigus vulgaris Patients after Treatment with Rituximab as Adjuvant

<b>Background:</b> B-cell depletion therapy was demonstrated to be a valid and safe alternative as an adjuvant in oral-pharyngeal pemphigus vulgaris (OPV) patients. We aimed to assess its effects on anti-desmoglein (Dsg) 1 and 3 and leukocytes subsets profile in these patients’ populatio...

Full description

Bibliographic Details
Main Authors: Giulio Fortuna, Elena Calabria, Massimo Aria, Amerigo Giudice, Michele Davide Mignogna
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Biomolecules
Subjects:
rituximab
remission
oral pemphigus vulgaris
disease severity
OPV
desmoglein
Online Access:https://www.mdpi.com/2218-273X/11/11/1634

Internet

https://www.mdpi.com/2218-273X/11/11/1634

Similar Items